Among older adults in Spain, hospitalisation rates from respiratory syncytial virus (RSV) infection increases progressively ...

A single dose of respiratory syncytial virus vaccine was effective against infections and associated hospitalizations in veterans aged at least 60 years during the 2023-24 season.

Among the viruses circulating most are COVID-19, flu and RSV. So far this season, the CDC estimates, there have been at least 24 million flu illnesses, 310,000 hospitalizations and 13,000 deaths ...

Among older adults in Spain, hospitalization rates from respiratory syncytial virus (RSV) infection increases progressively with age and is more likely among people with other health issues and who ...

It spreads through inhalation or contact with the fluids from an infected person's coughs or sneezes. 2 While often linked to infants and young children, RSV poses an even greater risk to older adults ...

Background: Prophylaxis against respiratory syncytial virus-associated hospitalization (RSV-H) with anti-RSV monoclonal antibody is not considered cost-effective for routine use in most jurisdictions.

There was no increase in the incidence or severity of adverse events ... such trials for various respiratory viruses, including RSV. The company has carried out 30 RSV challenge studies with ...

GSK to showcase latest research at the International RSV Symposium to advance RSV prevention in adults: London, UK Saturday, March 8, 2025, 14:00 Hrs [IST] GSK plc will share its ...

was conducted to identify published evidence on Respiratory Syncytial Virus (RSV) hospitalization incidence, number, and cost in adults, with a defined scope, inclusion criteria, and data ...

In the study, clesrovimab (MK-1654) significantly reduced the incidence of RSV disease and hospitalisations in healthy preterm and full-term infants, putting MSD in a position to potentially file ...